1262132-94-4Relevant articles and documents
Fused ring heteroaryl derivative as well as pharmaceutical composition and treatment method and application thereof
-
Paragraph 0144; 0155-0158, (2021/09/15)
The present invention relates to a fused ring heteroaryl derivative represented by formula (I) or a tautomer thereof. Use HIF of an optical isomer, an oxynitride, a solvate, or a pharmaceutically acceptable salt or prodrug thereof, for the treatment or al
TRIAZOLOPYRIDINE COMPOUND, AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR OR ERYTHROPOIETIN PRODUCTION-INDUCING AGENT
-
, (2011/04/19)
The present invention provides a triazolopyridine compound having a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability. The present invention relates to a compound represented by the following formula [I]: wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, as well as a prolyl hydroxylase inhibitor or erythropoietin production-inducing agent containing the compound. The compound of the present invention shows a prolyl hydroxylase inhibitory action and an erythropoietin production-inducing ability and is useful as a prophylactic or therapeutic agent for various diseases and pathologies (disorders) caused by decreased production of erythropoietin.